மருத்துவ கண்டறியும் முறைகளின் இதழ்
திறந்த அணுகல்

சுருக்கம்

A Novel Approach to Coronary CT Angiography Risk Stratification

Herlin Ray

CCTA (Coronary Computed Tomographic Angiography) has been shown to be a promising noninvasive method for assessing
Coronary Artery Disease (CAD) and cardiovascular risks. The existence, extent, and severity of CAD; coronary plaque burden;
and features that are highly correlated with those on invasive coronary angiography can all be determined with CCTA.
Furthermore, new CCTA techniques enable for the assessment of CAD's hemodynamic importance. CCTA has the potential
to be utilised in place of other invasive or noninvasive treatments. This study outlines risk classification for coronary artery
disease (CAD) based on morphological and hemodynamic information, coronary plaque features, and burden observed on
CCTA. Coronary Artery Disease (CAD) continues to be the world's leading cause of significant morbidity and mortality. Recent
sophisticated technologies allow patients with suspected CAD to estimate future cardiovascular risks by correcting a variety of
CAD factors using a variety of invasive and noninvasive techniques. Multiple methodologies, such as anatomical information,
which includes the presence, extent, and severity of CAD, hemodynamic information, and coronary plaque vulnerability, have
all been widely employed for risk classification and discriminating. The recent FAME studies addressed an important question
about how to best manage patients who would benefit from revascularization based on the hemodynamic or anatomical
importance of their CAD. The prospect trial also demonstrated the usefulness of using Intravascular Ultrasonography (IVUS)
to assess coronary plaque architecture, including severity, volume, and vulnerability, in predicting future cardiovascular risks.
Because these CAD aspects help with risk classification and medical management, it's crucial to know how to pick the right
patients and exams in a clinical context. Coronary Computed Tomographic Angiography (CCTA) is a noninvasive technique
for assessing the existence and severity of Coronary Artery Disease (CAD) and risk stratification in people who have it.
CCTA gives anatomical information, coronary plaque burden, and coronary plaque morphology that are not visible with ICA
because to the great spatial and temporal resolution. A recent upgraded technology of CCTA may also allow identifying the
hemodynamic relevance of CAD in addition to this benefit.The efficacy of CCTA in measuring anatomical and hemodynamic
factors, as well as detecting plaque shape and burden for risk stratification.